Isolation of Endogenous Anticoagulant N-Sulfated Glycosaminoglycans in Human Plasma from Healthy Subjects
暂无分享,去创建一个
[1] M. Ruggiero,et al. Heparin binding peptides co‐purify with glycosaminoglycans from human plasma , 1999, FEBS letters.
[2] S. Cavari,et al. Detection of heparin-like glycosaminoglycans in normal human plasma by polyacrylamide-gel electrophoresis. , 1996, Clinica chimica acta; international journal of clinical chemistry.
[3] P. Bianchini,et al. Relationship between plasma antifactor Xa activity and the antithrombotic activity of heparins of different molecular mass. , 1995, Haemostasis.
[4] J. Millet,et al. The effect of the beta-D-xyloside naroparcil on circulating plasma glycosaminoglycans. An explanation for its known antithrombotic activity in the rabbit. , 1995, The Journal of biological chemistry.
[5] N. Volpi,et al. Qualitative and quantitative studies of heparin and chondroitin sulfates in normal human plasma. , 1995, Biochimica et biophysica acta.
[6] R. Mulligan,et al. Pathway-specific regulation of the synthesis of anticoagulantly active heparan sulfate. , 1994, The Journal of biological chemistry.
[7] M. Masserini,et al. Modifications of low density lipoprotein induced by the interaction with human plasma glycosaminoglycan-protein complexes. , 1994, Biochimica et biophysica acta.
[8] S. Cavari,et al. Glycosaminoglycans exposed on the endothelial cell surface , 1993, FEBS letters.
[9] L. Stramaccia,et al. Endogenous heparinase-sensitive anticoagulant activity in human plasma. , 1992, Thrombosis research.
[10] A. Calatroni,et al. Characteristics of the interactions between acid glycosaminoglycans and proteins in normal human plasma as revealed by the behaviour of the protein-polysaccharide complexes in ultrafiltration and chromatographic procedures. , 1992, Clinica chimica acta; international journal of clinical chemistry.
[11] O. Wilson,et al. A heparin-like anticoagulant as part of global abnormalities of plasma glycosaminoglycans in a patient with transitional cell carcinoma. , 1991, The Journal of laboratory and clinical medicine.
[12] L. Magnelli,et al. Interaction between endogenous circulating sulfated-glycosaminoglycans and plasma proteins. , 1990, Clinica chimica acta; international journal of clinical chemistry.
[13] M. Lyon,et al. A general method for the detection and mapping of submicrogram quantities of glycosaminoglycan oligosaccharides on polyacrylamide gels by sequential staining with azure A and ammoniacal silver. , 1990, Analytical biochemistry.
[14] T. Anastassiades,et al. Electrophoresis of glycosaminoglycans isolated from normal human plasma. Direct evidence for the presence of a heparin-like molecule. , 1987, Biomedica biochimica acta.
[15] I. Staprans,et al. Isolation and characterization of glycosaminoglycans in human plasma. , 1985, The Journal of clinical investigation.
[16] U. Abildgaard,et al. Assay of unfractionated and LMW heparin with chromogenic substrates: twin methods with factor Xa and thrombin. , 1984, Thrombosis research.
[17] H. Gralnick,et al. Circulating heparan sulfate anticoagulant in a patient with a fatal bleeding disorder. , 1984, The New England journal of medicine.
[18] Denis R. Miller,et al. A heparin‐like anticoagulant in an 8‐month‐old boy with acute monoblastic leukemia , 1984, American journal of hematology.
[19] V. Chiarugi,et al. Adhesion-dependent heparin production by platelets , 1982, Nature.
[20] V. Chiarugi,et al. A new method for characterization of N-sulfated glycosaminoglycans by a rapid and multisample nitrous acid treatment during an electrophoretic run and its application to the analysis of biological samples. , 1980, Analytical biochemistry.
[21] R. Hata,et al. Low-sulfated chondroitin sulfate in human blood and urine. , 1978, Biochimica et biophysica acta.
[22] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[23] M. Lie,et al. Assay of heparin in plasma using a chromogenic substrate for activated factor X. , 1976, Thrombosis research.
[24] J. Hirsh,et al. A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. , 1972, The New England journal of medicine.
[25] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.